IceCure Medical (NASDAQ:ICCM – Get Free Report) and Globus Medical (NYSE:GMED – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, dividends, valuation and earnings.
Analyst Recommendations
This is a breakdown of recent recommendations for IceCure Medical and Globus Medical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| IceCure Medical | 0 | 0 | 2 | 0 | 3.00 |
| Globus Medical | 0 | 3 | 7 | 0 | 2.70 |
IceCure Medical presently has a consensus target price of $2.70, suggesting a potential upside of 390.91%. Globus Medical has a consensus target price of $77.78, suggesting a potential upside of 5.62%. Given IceCure Medical’s stronger consensus rating and higher possible upside, equities analysts plainly believe IceCure Medical is more favorable than Globus Medical.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| IceCure Medical | $3.34 million | 7.52 | -$14.65 million | ($0.33) | -1.67 |
| Globus Medical | $2.24 billion | 4.46 | $122.87 million | $0.64 | 115.06 |
Globus Medical has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares IceCure Medical and Globus Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| IceCure Medical | -410.22% | -111.27% | -81.41% |
| Globus Medical | 1.82% | 8.70% | 6.87% |
Risk and Volatility
IceCure Medical has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Comparatively, Globus Medical has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500.
Institutional & Insider Ownership
0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 95.2% of Globus Medical shares are held by institutional investors. 2.4% of IceCure Medical shares are held by insiders. Comparatively, 18.5% of Globus Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
Globus Medical beats IceCure Medical on 11 of the 14 factors compared between the two stocks.
About IceCure Medical
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
About Globus Medical
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.
